114 related articles for article (PubMed ID: 26358931)
1. Determinants of advanced stage presentation of breast cancer in 87,969 Brazilian women.
Abrahão Kde S; Bergmann A; Aguiar SS; Thuler LC
Maturitas; 2015 Dec; 82(4):365-70. PubMed ID: 26358931
[TBL] [Abstract][Full Text] [Related]
2. TNM staging and classification (familial and nonfamilial) of breast cancer in Jordanian females.
Atoum MF; Hourani HM; Shoter A; Al-Raheem SN; Al Muhrib TK
Indian J Cancer; 2010; 47(2):194-8. PubMed ID: 20448386
[TBL] [Abstract][Full Text] [Related]
3. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
4. Younger women with breast carcinoma have a poorer prognosis than older women.
Chung M; Chang HR; Bland KI; Wanebo HJ
Cancer; 1996 Jan; 77(1):97-103. PubMed ID: 8630946
[TBL] [Abstract][Full Text] [Related]
5. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
[TBL] [Abstract][Full Text] [Related]
6. Invasive breast cancer following ductal and lobular carcinoma in situ of the breast.
Levi F; Randimbison L; Te VC; La Vecchia C
Int J Cancer; 2005 Sep; 116(5):820-3. PubMed ID: 15838829
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer in Sabah, Malaysia: a two year prospective study.
Leong BD; Chuah JA; Kumar VM; Yip CH
Asian Pac J Cancer Prev; 2007; 8(4):525-9. PubMed ID: 18260722
[TBL] [Abstract][Full Text] [Related]
8. Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia.
Whiffen A; El-Tamer M; Taback B; Feldman S; Joseph KA
Ann Surg Oncol; 2011 Feb; 18(2):463-7. PubMed ID: 20878246
[TBL] [Abstract][Full Text] [Related]
9. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk factors in younger and older women.
Chun J; Pocock B; Joseph KA; El-Tamer M; Klein L; Schnabel F
Ann Surg Oncol; 2009 Jan; 16(1):96-9. PubMed ID: 18979140
[TBL] [Abstract][Full Text] [Related]
11. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
12. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
Freeman AB; Huang B; Dragun AE
Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
[TBL] [Abstract][Full Text] [Related]
13. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and pathological features of breast cancer in a population of Mexico].
Maffuz-Aziz A; Labastida-Almendaro S; Espejo-Fonseca A; Rodríguez-Cuevas S
Cir Cir; 2017; 85(3):201-207. PubMed ID: 27658545
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study.
Seneviratne S; Lawrenson R; Scott N; Kim B; Shirley R; Campbell I
PLoS One; 2015; 10(4):e0123523. PubMed ID: 25849101
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Systemic Therapy Use for Younger Patients with Breast Cancer Treated in Different Types of Cancer Centers Across the United States.
Mohiuddin JJ; Deal AM; Carey LA; Lund JL; Baker BR; Zagar TM; Jones EL; Marks LB; Chen RC
J Am Coll Surg; 2016 Nov; 223(5):717-728.e4. PubMed ID: 27788894
[TBL] [Abstract][Full Text] [Related]
18. Pathological features and prognosis of lobular carcinoma in Egyptian breast cancer patients.
Azim HA; Malek RA; Azim HA
Womens Health (Lond); 2014 Sep; 10(5):511-8. PubMed ID: 25335542
[TBL] [Abstract][Full Text] [Related]
19. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
20. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
